Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model
AUTOR(ES)
Takagi, Yasushi
FONTE
American Society for Clinical Investigation
RESUMO
Parkinson disease (PD) is a neurodegenerative disorder characterized by loss of midbrain dopaminergic (DA) neurons. ES cells are currently the most promising donor cell source for cell-replacement therapy in PD. We previously described a strong neuralizing activity present on the surface of stromal cells, named stromal cell–derived inducing activity (SDIA). In this study, we generated neurospheres composed of neural progenitors from monkey ES cells, which are capable of producing large numbers of DA neurons. We demonstrated that FGF20, preferentially expressed in the substantia nigra, acts synergistically with FGF2 to increase the number of DA neurons in ES cell–derived neurospheres. We also analyzed the effect of transplantation of DA neurons generated from monkey ES cells into 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine–treated (MPTP-treated) monkeys, a primate model for PD. Behavioral studies and functional imaging revealed that the transplanted cells functioned as DA neurons and attenuated MPTP-induced neurological symptoms.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=539189Documentos Relacionados
- Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model
- Generation of neural crest-derived peripheral neurons and floor plate cells from mouse and primate embryonic stem cells
- Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease
- Functional characterization of B lymphocytes generated in vitro from embryonic stem cells
- Derivation of midbrain dopamine neurons from human embryonic stem cells